Immunochemical analysis of CD107a (LAMP-1)

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• CD107a, or lysosome associated membrane protein-1 (LAMP-1), is crucial for cellular functions and implicated in cancer metastasis.
• LAMP-1 serves as a marker for lysosomal storage disorders and cytotoxic T cells, necessitating well-characterized immune-reagents.
• Accurate detection of LAMP-1 is vital due to its diverse cellular roles and potential therapeutic applications.

Purpose of the Study:

• To characterize a novel monoclonal antibody (80280) targeting LAMP-1.
• To compare the performance of antibody 80280 against existing monoclonal (BB6) and polyclonal antibodies for LAMP-1 detection.
• To investigate the epitope specificity and reactivity of the new monoclonal antibody.

Main Methods:

• Immunofluorescence microscopy was used to compare antibody staining patterns.
• Epitope mapping via peptide reactivity assays was performed.
• Western blotting was employed to assess antibody activity and compare it with existing reagents.

Main Results:

• All tested antibodies (80280, BB6, polyclonal) showed similar results in immunofluorescence.
• Monoclonal antibody 80280 exhibited no reactivity to LAMP-1 peptides, suggesting a potential carbohydrate epitope.
• Western blotting indicated weaker activity for antibody 80280 compared to BB6 monoclonal and polyclonal antibodies.

Conclusions:

• Monoclonal antibody 80280 is distinct from the BB6 antibody, offering a new option for CD107a analysis.
• The distinct epitope reactivity of antibody 80280 may provide unique insights into LAMP-1 biology.
• Further characterization is warranted to fully elucidate the utility of antibody 80280 in various applications.